Results 161 to 170 of about 5,084 (185)

Phase I/II Study of Tifcemalimab, an Anti-B and T-lymphocyte Attenuator Antibody, in Combination with Toripalimab in Previously Treated Advanced Lung Cancer.

Clinical Cancer Research
PURPOSE Tifcemalimab is a recombinant humanized IgG4k monoclonal antibody targeting B and T-lymphocyte attenuator (BTLA). Co-blockade of BTLA and programmed death-1 pathways improved outcomes in non-clinical models.
Ying Cheng, Jie Wang, Yan Yu, Qi-Ming Wang, Run-Xiang Yang, Bing Xia, Chong Li, Dong-Qing Lv, T. Yi, Liang Han, Xiao-Qing Liu, Xicheng Wang, Wei Zhang, Man Su, Minjie Shen, Jing Xu, Bang-An Peng   +16 more
semanticscholar   +1 more source

The Function of B and T Lymphocyte Attenuator and Its Role in Transplantation

Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS)
Immune checkpoints are important molecules that regulate the immune response, preventing its overactivation from causing tissue damage and autoimmune diseases.
Kai Ma, Heqiao Han, Yuchen Bao, Rongtao Chen, Yi-Xuan Yang, Wen-Wei Shao   +5 more
semanticscholar   +1 more source

B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator

Nature Immunology, 2005
J. Sedy, Maya Gavrieli, Karen G. Potter, Michelle A. Hurchla, R. C. Lindsley, K. Hildner, S. Scheu, K. Pfeffer, C. F. Ware, T. Murphy, Kenneth M. Murphy   +10 more
semanticscholar   +1 more source

B and T lymphocyte attenuator (BTLA)

Science-Business eXchange, 2010
openaire   +1 more source

B and T lymphocyte attenuator (BTLA)

Science-Business eXchange, 2014
openaire   +1 more source

B AND T LYMPHOCYTE ATTENUATOR (BTLA) MODULATORS AND METHOD OF USING SAME

2023
DAHL MARTIN EDWARD, PARMLEY STEPHEN, LIZZUL PAUL, HARE ERIC   +3 more
openaire   +1 more source

B AND T LYMPHOCYTE ATTENUATOR (BTLA) MODULATORS AND METHOD OF USING SAME

2022
DAHL MARTIN EDWARD, PARMLEY STEPHEN, KEHRY MARILYN, CORREIA JEAN DA SILVA, SHAW MORENA   +4 more
openaire   +1 more source

Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2.

Biochemical and Biophysical Research Communications - BBRC, 2003
Maya Gavrieli, N. Watanabe, S. Loftin, T. Murphy, K. Murphy   +4 more
semanticscholar   +1 more source

Beating (T-lymphocyte driven) atherosclerosis with B- and T-lymphocyte attenuator

Cardiovascular Research, 2020
Andrew Sage, Meritxell Edurne Nus Chimeno, Ziad Mallat   +2 more
exaly  

B and T lymphocyte attenuator regulates CD8+ T cell–intrinsic homeostasis and memory cell generation

Nature Immunology, 2007
C. Krieg, O. Boyman, Yang-Xin Fu, J. Kaye   +3 more
semanticscholar   +1 more source